General MedicationsORALGeneric
SULINDAC
SULINDAC
Standard Dose
150MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SULINDAC is listed in Drugs@FDA under application 073262 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient SULINDAC Form and strength TABLET;ORAL - 150MG Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2024-11-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview SULINDAC is listed in Drugs@FDA under application 073262 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient SULINDAC Form and strength TABLET;ORAL - 150MG Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2024-11-21 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.